Gubra A/S (CPH: GUBRA)

Market Cap	9.95B
Revenue (ttm)	223.82M
Net Income (ttm)	-46.53M
Shares Out	16.31M
EPS (ttm)	-2.81
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138,422
Open	708.00
Previous Close	708.00
Day's Range	544.00 - 708.00
52-Week Range	114.00 - 754.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 28, 2025

About Gubra

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs in Denmark and internationally. The company operates through CRO, Discovery & Partnerships, and Gubra Green segments. It offers pre-clinical contract research and development services within metabolic and fibrotic diseases for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, assays and molecular pharmacology, bioinformat...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 220
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: GUBRA